Myung Sun Kim (Myung S Kim)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Toll Like Receptor

Immune Response

Chronic Lymphocytic Leukemia

Top Venues

American journal of hematology

Case reports in hematology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Myung Sun Kim, Vinay Prasad
Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy. American journal of hematology (2023)
Myung Sun Kim, Vinay Prasad
Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy. American journal of hematology 98 (4) (2023)
Myung Sun Kim, Vinay Prasad
Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy. American journal of hematology 98 (4) (2023)
Myung Sun Kim, Vinay Prasad
Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy. American journal of hematology 98 (4) (2023)
Myung Sun Kim, Vinay Prasad
Front-line CLL: the role of chemoimmunotherapy. American journal of hematology (2023)
Zoe L Lyski, Myung Sun Kim, David Xthona Lee, David Sampson, Hans-Peter Raué, Vikram Raghunathan, Debbie Ryan, Amanda E Brunton, Mark K Slifka, William B Messer, Stephen E Spurgeon
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia. Case reports in hematology 2022 (2022)
Myung Sun Kim, Alexander Xu, Alyson Haslam, Vinay Prasad
Quality of biomarker defined subgroups in FDA approvals of PD-1/PD-L1 inhibitors 2014 to 2020. International journal of cancer 150 (11) (2022)
Zoe Lyski, Myung Sun Kim, David Xthona Lee, Hans-Peter Raué, Vikram Raghunathan, Janet Griffin, Debbie Ryan, Amanda E Brunton, Marcel E Curlin, Mark K Slifka, William B Messer, Stephen E Spurgeon
Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia. Blood advances (2021)